New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:52 EDTAGTC, SGMO, ISIS, INO, IDRA, CLDN, BMRN, BLUE, ARWR, ALNY, SRPTPiper Jaffray to hold a symposium
GenomeRX Symposium to be held in New York on June 23.
News For AGTC;ALNY;ARWR;BLUE;BMRN;CLDN;IDRA;INO;ISIS;SGMO;SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
October 9, 2014
12:06 EDTSRPTLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
11:00 EDTARWROptions with increasing implied volatility
Options with increasing implied volatility: ARWR PBR EXXI PWE GST GLNG WTW AFSI ETE VALE
10:00 EDTARWROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:38 EDTARWRArrowhead price target lowered to $12 from $24 at Piper Jaffray
Subscribe for More Information
08:33 EDTARWRArrowhead issues letter to shareholders regarding ARC-520
Subscribe for More Information
07:02 EDTISISIsis Pharmaceuticals receives $18M milestone payment from GlaxoSmithKline
Subscribe for More Information
06:18 EDTARWRArrowhead downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Arrowhead to Sector Perform citing low-end efficacy in the AASLD abstract. Price target lowered to $9.
05:50 EDTARWRStocks with implied volatility movement; ARWR TKMR
Stocks with implied volatility movement; Arrowhead (ARWR) 158, Tekmira (TKMR) 130 according to iVolatility.
October 8, 2014
16:26 EDTARWROn The Fly: Closing Wrap
Subscribe for More Information
13:12 EDTARWRArrowhead risk/reward favorable, says Deutsche Bank
Subscribe for More Information
11:48 EDTARWRArrowhead sell-off overdone, long-term view unchanged, says Jefferies
Subscribe for More Information
11:22 EDTSRPTChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
11:10 EDTISIS, ARWROptions with increasing implied volatility
Subscribe for More Information
10:55 EDTARWRArrowhead ARC-520 treatment effect much lower than expected, TheStreet says
Subscribe for More Information
10:46 EDTARWRArrowhead plunges after HepB data abstract posted
Subscribe for More Information
October 7, 2014
16:13 EDTAGTCPoint72 Asset reports 5.8% passive stake in Applied Genetic
Subscribe for More Information
10:56 EDTISISOptions with increasing implied volatility
Subscribe for More Information
07:29 EDTINOBernstein to hold a conference
Genes as Drugs Event is being held in New York on October 7.
07:24 EDTSGMO, BLUEAlliance for Regenerative Medicine
Subscribe for More Information
07:16 EDTBLUEBiotech Industry Organization to hold a forum
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use